GSK, U.S. Government Experimental Ebola Vaccine Shown To Be Safe In Human Trials: NIH

An experimental Ebola vaccine developed by GlaxoSmithKline and the U.S. government was found to be safe for use in human trials, the National Institutes of Health announced Wednesday. "Based on these positive results from the first human trial of this candidate vaccine, we are continuing our accelerated plan for larger trials to determine if the vaccine is efficacious in preventing Ebola infection," Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NI...